Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose erythromycin for stable COPD
ChiCTR-TRC-09000367Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of erythromycin in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Neutrophil elastase level, Acute exacerbation and 2 more. Started Apr 2008; status: completed.
02
Drugs
erythromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000367.